Co-Diagnostics, Inc.
News
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
PR Newswire Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test PR Newswire SALT LAKE CITY, Sept. 5...\n more…
Co-Diagnostics (NASDAQ:CODX) adds US$8.6m to market cap in the past 7 days, though investors from three years ago are still down 87%
Simply Wall St It is doubtless a positive to see that the Co-Diagnostics, Inc. ( NASDAQ:CODX ) share price has gained some 32% in the...\n more…
HC Wainwright Research Analysts Boost Earnings Estimates for Co-Diagnostics, Inc. (NASDAQ:CODX)
Ticker Report Co-Diagnostics, Inc. (NASDAQ:CODX - Free Report) - HC Wainwright boosted their Q3 2024 earnings per share estimates for shares of Co-Diagnostics in a note issued to investors on Monday, August 12th...\n more…
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
PR Newswire Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. PR Newswire SALT LAKE CITY...\n more…
HC Wainwright Lowers Co-Diagnostics (NASDAQ:CODX) Price Target to $1.50
Ticker Report Co-Diagnostics (NASDAQ:CODX - Get Free Report) had its target price reduced by investment analysts at HC Wainwright from $2.00 to $1.50 in a research note issued on Monday, Benzinga reports. The firm...\n more…
Hold Rating Maintained for Co-Diagnostics Amidst Revenue Growth and Development Progress
TipRanks Financial Blog Co-Diagnostics (CODX - Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yi Chen from H.C. Wai...\n more…